After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Phathom Pharmaceuticals Inc is $1.27B. A total of 1.26 million shares were traded on the day, compared to an average of 1.09M shares.
In the most recent transaction, Breedlove Robert Charles sold 524 shares of PHAT for 13.51 per share on Nov 03 ’25. After the transaction, the Principal Accounting Officer now owns 47,407 company shares. In a previous transaction on Sep 05 ’25, Breedlove Robert Charles sold 461 shares at 12.09 per share. PHAT shares that Principal Accounting Officer owns now total 47,931.
Among the insiders who sold shares, Breedlove Robert Charles disposed of 1,692 shares on Jul 16 ’25 at a per-share price of $8.36. This resulted in the Principal Accounting Officer holding 48,392 shares of PHAT after the transaction. In another insider transaction, Topper James N bought 3,780 shares at $3.86 per share on May 21 ’25. Company shares held by the Director now total 59,403.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, PHAT has a high of $17.70 and a low of $2.21.
As of this writing, PHAT has an earnings estimate of -$0.2 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.09 per share and a lower estimate of -$0.41. The company reported an EPS of -$1.05 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PHAT’s latest balance sheet shows that the firm has $183.26M in Cash & Short Term Investments as of fiscal 2021. There were $91.34M in debt and $18.92M in liabilities at the time. Its Book Value Per Share was -$5.95, while its Total Shareholder’s Equity was $72.16M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PHAT is Buy with a score of 4.36.
